The Emergence of GPR119 Agonists as Anti-Diabetic Agents

被引:48
作者
Jones, Robert M. [1 ]
Leonard, James N. [1 ]
机构
[1] Arena Pharmaceut, San Diego, CA 92121 USA
来源
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44 | 2009年 / 44卷
关键词
PROTEIN-COUPLED RECEPTOR; GLUCAGON-LIKE PEPTIDE-1; GASTROINTESTINAL-TRACT; INSULIN-SECRETION; GLYCEMIC CONTROL; G-PROTEIN-COUPLED-RECEPTOR-119; OLEOYLETHANOLAMIDE; DISCOVERY; DOPAMINE; RELEASE;
D O I
10.1016/S0065-7743(09)04407-8
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
[No abstract available]
引用
收藏
页码:149 / 170
页数:22
相关论文
共 70 条
  • [1] Alper P., 2008, WO Pat. Appl., Patent No. 2008097428
  • [2] AMMALA C, 2008, KEYST S ISL BET CELL
  • [3] Ammala C., 2008, Patent No. [2008008895, WO 2008/008895A1]
  • [4] [Anonymous], 2007, Patent, Patent No. [WO 2007116229, 2007116229]
  • [5] [Anonymous], 2008, Patent, Patent No. [2008109702, WO 2008109702]
  • [6] [Anonymous], 2009, Patent, Patent No. [WO 2009014910, 2009014910]
  • [7] [Anonymous], 2008, Patent, Patent No. [2008025799, WO 2008025799]
  • [8] *AR PHARM, 2004, AR PHARM ANN SEL 2 A
  • [9] *AR PHARM, 2008, AR PHARM ANN APD668
  • [10] *AR PHARM, 2006, AR PHARM ANN ORTH EX